Annual EBITDA
-$19.03 M
+$19.22 M+50.24%
December 31, 2023
Summary
- As of February 7, 2025, ZEPP annual EBITDA is -$19.03 million, with the most recent change of +$19.22 million (+50.24%) on December 31, 2023.
- During the last 3 years, ZEPP annual EBITDA has fallen by -$64.73 million (-141.65%).
- ZEPP annual EBITDA is now -119.63% below its all-time high of $96.94 million, reached on December 31, 2019.
Performance
ZEPP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$11.51 M
-$2.42 M-26.57%
September 30, 2024
Summary
- As of February 7, 2025, ZEPP quarterly EBITDA is -$11.51 million, with the most recent change of -$2.42 million (-26.57%) on September 30, 2024.
- Over the past year, ZEPP quarterly EBITDA has dropped by -$13.50 million (-676.69%).
- ZEPP quarterly EBITDA is now -129.76% below its all-time high of $38.66 million, reached on December 31, 2019.
Performance
ZEPP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$31.66 M
-$13.50 M-74.35%
September 30, 2024
Summary
- As of February 7, 2025, ZEPP TTM EBITDA is -$31.66 million, with the most recent change of -$13.50 million (-74.35%) on September 30, 2024.
- Over the past year, ZEPP TTM EBITDA has increased by +$6.66 million (+17.38%).
- ZEPP TTM EBITDA is now -133.55% below its all-time high of $94.35 million, reached on December 31, 2019.
Performance
ZEPP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ZEPP EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +50.2% | -676.7% | +17.4% |
3 y3 years | -141.7% | -209.8% | -178.8% |
5 y5 years | -133.8% | -137.4% | -172.3% |
ZEPP EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -160.4% | +50.2% | -292.7% | +45.5% | -232.5% | +41.6% |
5 y | 5-year | -119.6% | +50.2% | -129.8% | +45.5% | -133.6% | +41.6% |
alltime | all time | -119.6% | +50.2% | -129.8% | +45.5% | -133.6% | +41.6% |
Zepp Health EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$11.51 M(+26.6%) | -$31.66 M(+74.3%) |
Jun 2024 | - | -$9.09 M(-28.8%) | -$18.16 M(-0.1%) |
Mar 2024 | - | -$12.77 M(-849.3%) | -$18.18 M(-31.5%) |
Dec 2023 | -$19.03 M(-50.2%) | $1.70 M(-14.6%) | -$26.54 M(-30.7%) |
Sep 2023 | - | $2.00 M(-121.9%) | -$38.32 M(-16.3%) |
Jun 2023 | - | -$9.11 M(-56.9%) | -$45.80 M(-15.5%) |
Mar 2023 | - | -$21.13 M(+109.7%) | -$54.23 M(+12.0%) |
Dec 2022 | -$38.25 M(-221.4%) | -$10.08 M(+83.5%) | -$48.43 M(+49.5%) |
Sep 2022 | - | -$5.49 M(-68.7%) | -$32.39 M(+97.2%) |
Jun 2022 | - | -$17.54 M(+14.4%) | -$16.42 M(-209.8%) |
Mar 2022 | - | -$15.33 M(-356.7%) | $14.95 M(-37.5%) |
Dec 2021 | $31.51 M(-31.0%) | $5.97 M(-43.0%) | $23.90 M(-40.5%) |
Sep 2021 | - | $10.47 M(-24.3%) | $40.18 M(-8.2%) |
Jun 2021 | - | $13.83 M(-316.9%) | $43.76 M(+26.9%) |
Mar 2021 | - | -$6.38 M(-128.7%) | $34.48 M(-21.3%) |
Dec 2020 | $45.70 M | $22.25 M(+58.2%) | $43.82 M(-27.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | $14.06 M(+209.1%) | $60.23 M(-21.7%) |
Jun 2020 | - | $4.55 M(+53.8%) | $76.92 M(-10.3%) |
Mar 2020 | - | $2.96 M(-92.3%) | $85.75 M(-9.1%) |
Dec 2019 | $96.94 M(+72.3%) | $38.66 M(+25.7%) | $94.35 M(+26.2%) |
Sep 2019 | - | $30.76 M(+130.0%) | $74.76 M(+19.8%) |
Jun 2019 | - | $13.37 M(+15.7%) | $62.42 M(-2.4%) |
Mar 2019 | - | $11.56 M(-39.4%) | $63.98 M(+18.9%) |
Dec 2018 | $56.26 M(+104.4%) | $19.07 M(+3.6%) | $53.83 M(+15.1%) |
Sep 2018 | - | $18.41 M(+23.2%) | $46.75 M(+28.1%) |
Jun 2018 | - | $14.94 M(+964.1%) | $36.50 M(+21.1%) |
Mar 2018 | - | $1.40 M(-88.3%) | $30.13 M(+7.8%) |
Dec 2017 | $27.52 M(+1061.0%) | $11.99 M(+47.0%) | $27.94 M(+24.2%) |
Sep 2017 | - | $8.16 M(-4.8%) | $22.49 M(+57.0%) |
Jun 2017 | - | $8.57 M(-1188.7%) | $14.33 M(+148.9%) |
Mar 2017 | - | -$787.30 K(-112.0%) | $5.76 M(-12.0%) |
Dec 2016 | $2.37 M(-137.4%) | $6.54 M | $6.54 M |
Dec 2015 | -$6.34 M | - | - |
FAQ
- What is Zepp Health annual EBITDA?
- What is the all time high annual EBITDA for Zepp Health?
- What is Zepp Health annual EBITDA year-on-year change?
- What is Zepp Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Zepp Health?
- What is Zepp Health quarterly EBITDA year-on-year change?
- What is Zepp Health TTM EBITDA?
- What is the all time high TTM EBITDA for Zepp Health?
- What is Zepp Health TTM EBITDA year-on-year change?
What is Zepp Health annual EBITDA?
The current annual EBITDA of ZEPP is -$19.03 M
What is the all time high annual EBITDA for Zepp Health?
Zepp Health all-time high annual EBITDA is $96.94 M
What is Zepp Health annual EBITDA year-on-year change?
Over the past year, ZEPP annual EBITDA has changed by +$19.22 M (+50.24%)
What is Zepp Health quarterly EBITDA?
The current quarterly EBITDA of ZEPP is -$11.51 M
What is the all time high quarterly EBITDA for Zepp Health?
Zepp Health all-time high quarterly EBITDA is $38.66 M
What is Zepp Health quarterly EBITDA year-on-year change?
Over the past year, ZEPP quarterly EBITDA has changed by -$13.50 M (-676.69%)
What is Zepp Health TTM EBITDA?
The current TTM EBITDA of ZEPP is -$31.66 M
What is the all time high TTM EBITDA for Zepp Health?
Zepp Health all-time high TTM EBITDA is $94.35 M
What is Zepp Health TTM EBITDA year-on-year change?
Over the past year, ZEPP TTM EBITDA has changed by +$6.66 M (+17.38%)